Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-12 · accession 0001069530-23-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-12 | FLNA | SCANNON PATRICK J MD PHD | Dir | M - OptEx | $0.95 | +1,000 | 1,000 | New | +$950 |
| D | 2023-06-12 | 2023-06-12 | FLNA | SCANNON PATRICK J MD PHD | Dir | M - OptEx | $0.95 | -1,000 | 9,000 | -10% | -$950 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-12 | M | A | 1,000 | $0.95 | 1,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-12 | M | D | 1,000 | $0.95 | 9,000 | D | $0.95 · 2022-09-14 to 2028-09-14 | 1,000 Common Stock |